Rampart Investment Management Company Has Increased Its Jpmorgan Chase & Co (JPM) Stake; Rock Springs Capital Management LP Has Upped Align Technology (ALGN) Position

February 24, 2018 - By Peter Erickson

Rock Springs Capital Management Lp increased Align Technology Inc (ALGN) stake by 166.52% reported in 2017Q3 SEC filing. Rock Springs Capital Management Lp acquired 38,300 shares as Align Technology Inc (ALGN)’s stock rose 36.03%. The Rock Springs Capital Management Lp holds 61,300 shares with $11.42 million value, up from 23,000 last quarter. Align Technology Inc now has $21.25 billion valuation. The stock increased 2.08% or $5.39 during the last trading session, reaching $265.07. About 939,952 shares traded. Align Technology, Inc. (NASDAQ:ALGN) has risen 82.22% since February 24, 2017 and is uptrending. It has outperformed by 65.52% the S&P500.

Rampart Investment Management Company Llc increased Jpmorgan Chase & Co (JPM) stake by 8.22% reported in 2017Q3 SEC filing. Rampart Investment Management Company Llc acquired 3,319 shares as Jpmorgan Chase & Co (JPM)’s stock declined 6.04%. The Rampart Investment Management Company Llc holds 43,688 shares with $4.17M value, up from 40,369 last quarter. Jpmorgan Chase & Co now has $401.77 billion valuation. The stock increased 2.03% or $2.33 during the last trading session, reaching $117.31. About 12.16M shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since February 24, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Since February 2, 2018, it had 1 buy, and 1 insider sale for $11.56 million activity. The insider Wright Emory sold $11.91M. HOGAN JOSEPH M had bought 1,500 shares worth $350,445 on Tuesday, February 13.

Among 13 analysts covering Align Technology (NASDAQ:ALGN), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Align Technology had 53 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, December 4 by Leerink Swann. Bank of America upgraded the stock to “Buy” rating in Friday, July 28 report. The firm has “Buy” rating given on Wednesday, January 31 by Jefferies. The firm has “Buy” rating by Roth Capital given on Friday, July 28. The firm earned “Buy” rating on Monday, November 28 by Stifel Nicolaus. Stifel Nicolaus maintained Align Technology, Inc. (NASDAQ:ALGN) rating on Tuesday, November 21. Stifel Nicolaus has “Buy” rating and $265.0 target. The rating was initiated by Deutsche Bank with “Hold” on Friday, December 8. The firm has “Buy” rating given on Tuesday, July 4 by Jefferies. The firm has “Buy” rating given on Friday, October 23 by Stifel Nicolaus. The firm earned “Buy” rating on Wednesday, October 18 by Robert W. Baird.

Investors sentiment decreased to 0.93 in Q3 2017. Its down 0.46, from 1.39 in 2017Q2. It turned negative, as 36 investors sold ALGN shares while 194 reduced holdings. 77 funds opened positions while 137 raised stakes. 62.92 million shares or 1.48% more from 62.01 million shares in 2017Q2 were reported. Columbia Wanger Asset Mgmt Ltd Co accumulated 637,971 shares. Ithaka Grp Inc Ltd Liability Company owns 48,649 shares. Prelude Cap Mgmt Lc reported 261 shares stake. Glenmede Tru Na holds 0.04% or 46,552 shares. Raymond James And Assoc reported 84,580 shares. Princeton Port Strategies Gp Incorporated invested in 7,462 shares. Capital Finance Advisers Limited Liability Co stated it has 26,533 shares. Whittier stated it has 0% in Align Technology, Inc. (NASDAQ:ALGN). 18,756 were reported by Autus Asset Mgmt Limited Liability. Riverhead Cap Mgmt Ltd Liability reported 4,800 shares stake. Private Wealth Prtnrs Ltd Liability invested in 1,560 shares. M&T Bankshares accumulated 12,649 shares. Brighton Jones Limited Liability Com stated it has 0.1% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN). Assetmark has invested 0% in Align Technology, Inc. (NASDAQ:ALGN). Pinebridge Invs Limited Partnership holds 0% or 234 shares.

Rock Springs Capital Management Lp decreased G1 Therapeutics Inc stake by 72,188 shares to 240,000 valued at $5.97M in 2017Q3. It also reduced Spark Therapeutics Inc (NASDAQ:ONCE) stake by 28,000 shares and now owns 597,000 shares. Audentes Therapeutics Inc was reduced too.

Among 33 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 13 Hold. Therefore 55% are positive. JPMorgan Chase & Co had 111 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, January 2 by Barclays Capital. The stock of JPMorgan Chase & Co. (NYSE:JPM) earned “Neutral” rating by Nomura on Monday, January 25. On Friday, August 28 the stock rating was downgraded by Vetr to “Strong-Buy”. UBS upgraded the stock to “Buy” rating in Friday, February 5 report. Jefferies maintained JPMorgan Chase & Co. (NYSE:JPM) on Wednesday, October 7 with “Buy” rating. The firm has “Hold” rating given on Wednesday, November 15 by Robert W. Baird. Buckingham Research downgraded it to “Neutral” rating and $74 target in Monday, October 17 report. The stock of JPMorgan Chase & Co. (NYSE:JPM) has “Hold” rating given on Tuesday, October 3 by Keefe Bruyette & Woods. The firm earned “Buy” rating on Tuesday, September 1 by Vetr. The stock of JPMorgan Chase & Co. (NYSE:JPM) earned “Outperform” rating by BMO Capital Markets on Wednesday, September 16.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: